about
Endothelin-1 increases cholinergic nerve-mediated contraction of human bronchi via tachykinin synthesis inductionGuidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendationsAcute asthma: emergency department management and prospective evaluation of outcome.Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.Adverse reaction to ipratropium bromide.Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.New drugs in respiratory disorders: IHow long should Atrovent be given in acute asthma?Nebulisers for asthma.Salbutamol and ipratropium in acute asthma.Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea-pig model of allergic asthma.Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearanceRecent advances in respiratory medicine.Audit of nebuliser useIpratropium bromide and fenoterol by aerosolized solution.Therapeutic aerosols 2--Drugs available by the inhaled route.Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.Intravenous β agonist in severe acute asthma: Author's reply.Treatment of respiratory failure: a review
P2860
Q28365369-6BAD91B2-8EE7-4E52-A03E-F87851C9763EQ28392274-F83CC92F-2233-4F36-99A6-6279C3DB76A5Q34577793-916009EA-E17A-44A6-ACBF-FAC96C12FA9EQ34712368-DEF6F5FF-24A7-44A0-A091-56477EC036FEQ34764442-366816F3-961C-4789-9BA1-E2E5C23A0CB1Q34903093-AD843AEA-4E77-4558-84E0-70766869EC7BQ34991426-0A588D79-4B26-4710-949B-253531CCD9BBQ35532403-F9DC3E2B-AEA2-4D89-AB37-2BBBD8490725Q35577134-74E54F36-744C-42EB-81F7-10115DB62878Q35603928-C4DB7447-AE7F-4A0A-9CC9-A8EDF8BC0CD2Q36024959-70C4EC3A-D882-4BCC-937E-50F7079547D3Q36135849-FEA6CF09-99CC-4601-BC3A-CD48C1C9B8A2Q36154134-54B580CB-70F7-4F2D-9879-115E2BD0DD71Q36704303-88C9BAA9-384E-4005-A24B-D71E120F867CQ38946562-3BBEAF98-B9A6-48C7-8AC9-7B14E93D4544Q39563156-8A162A72-1B4C-492E-8F61-490BAD535C06Q40093004-3E14C1B1-C65E-48E2-BF9E-EBCE3235FCA8Q41231716-328FC5F1-2F9D-4212-B5FD-4B69172BAADCQ45758535-8181F6B7-2A9A-473E-B743-EF73C95AB326Q58317081-DFB628C0-ED14-4354-8702-6562CF2BCC1E
P2860
description
1981 nî lūn-bûn
@nan
1981 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Ipratropium bromide in acute asthma.
@ast
Ipratropium bromide in acute asthma.
@en
Ipratropium bromide in acute asthma.
@nl
type
label
Ipratropium bromide in acute asthma.
@ast
Ipratropium bromide in acute asthma.
@en
Ipratropium bromide in acute asthma.
@nl
prefLabel
Ipratropium bromide in acute asthma.
@ast
Ipratropium bromide in acute asthma.
@en
Ipratropium bromide in acute asthma.
@nl
P2093
P2860
P356
P1433
P1476
Ipratropium bromide in acute asthma
@en
P2093
P2860
P304
P356
10.1136/BMJ.282.6264.598
P407
P577
1981-02-01T00:00:00Z